Revance Therapeutics shares owned by Calamos Advisors
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Calamos Advisors
from 13F filings
Historical chart of Calamos Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Calamos Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.0M | 4.0M | 0.76 |
2023-09-30 | $3.2M | 4.0M | 0.81 |
2023-06-30 | $4.2M | 4.0M | 1.05 |
2023-03-31 | $4.9M | 4.0M | 1.24 |
2022-12-31 | $3.7M | 4.0M | 0.93 |
2022-09-30 | $4.3M | 4.0M | 1.08 |
2022-06-30 | $3.3M | 4.0M | 0.84 |
2022-03-31 | $3.8M | 4.0M | 0.94 |
2021-12-31 | $3.6M | 4.0M | 0.89 |
2021-09-30 | $4.6M | 4.0M | 1.15 |
2021-06-30 | $4.7M | 4.0M | 1.17 |
2021-03-31 | $4.5M | 4.0M | 1.13 |